Lv52
920 积分 2025-01-15 加入
Development of an Orally Bioavailable LCK PROTAC Degrader as a Potential Therapeutic Approach to T-Cell Acute Lymphoblastic Leukemia
7天前
已完结
Discovery of the First Clinical Protein Degrader for the Treatment of Autoimmune Indications: Orally Bioavailable and Selective IRAK4 Degrader KT-474
7天前
已完结
Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer
7天前
已完结
Radioactive ADME Demonstrates ARV-110’s High Druggability Despite Low Oral Bioavailability
7天前
已完结
Physicochemical Property Determinants of Oral Absorption for PROTAC Protein Degraders
10天前
已完结
Early evaluation of opportunities in oral delivery of PROTACs to overcome their molecular challenges
10天前
已完结
Dronedarone Enhances the Antibacterial Activity of Polymyxin B and Inhibits the Quorum Sensing System by Interacting with LuxS
13天前
已完结
Wound healing in second-degree burns in rats treated with silver sulfadiazine: a systematic review and meta-analysis
18天前
已完结
AI-directed formulation strategy design initiates rational drug development
20天前
已完结
In silico formulation prediction of drug/cyclodextrin/polymer ternary complexes by machine learning and molecular modeling techniques
20天前
已完结
皖公网安备34019202002308
